help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shinyama, H.
Right arrow Articles by Flier, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shinyama, H.
Right arrow Articles by Flier, J. S.
Endocrinology Vol. 144, No. 4 1301-1314
Copyright © 2003 by The Endocrine Society

ARTICLE

Regulation of Melanocortin-4 Receptor Signaling: Agonist-Mediated Desensitization and Internalization

Hiroshi Shinyama, Hiroaki Masuzaki, Hui Fang and Jeffrey S. Flier

Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215

Address all correspondence and requests for reprints to: Jeffrey S. Flier, M.D., Beth Israel Deaconess Medical Center, Finard 204, 330 Brookline Avenue, Boston, Massachusetts 02215. E-mail: jflier{at}caregroup.harvard.edu.

Disruption of the hypothalamic melanocortin-4 receptor (MC4R) pathway results in obesity both in humans and rodents, demonstrating a crucial role for hypothalamic MC4Rs in the regulation of energy homeostasis. Because even haploinsufficiency of the MC4R gene can cause obesity in humans and mice, subtle changes in receptor numbers or signaling are likely to impact upon the regulation of food intake and energy expenditure. Little is known about the intracellular regulation of MC4R signaling. Using GT1–7 cells, we show for the first time that the MC4R undergoes ligand-mediated desensitization. We then addressed the possible mechanisms underlying the desensitization using HEK293 and COS-1 cells transfected with hemagglutinin-tagged human MC4R. Preexposure of GT1–7 cells that express endogenous MC4R to the agonist for MC4R, {alpha}-melanocyte-stimulating hormone, resulted in impaired cAMP formation to a second challenge of {alpha}-melanocyte-stimulating hormone. The desensitization of MC4R was accompanied by time-dependent internalization of the receptor in HEK293 cells, which was partly inhibited by pretreatment with a specific protein kinase A (PKA) inhibitor, H89. In COS-1 cells, overexpression of dominant-negative G protein-coupled receptor kinase (GRK) 2-K220R partly inhibited the agonist-mediated internalization of MC4R, whereas it did not in HEK293 cells. Overexpression of dominant-negative mutants of ß-arrestin1-V53D and dynamin I-K44A prevented agonist-mediated internalization of MC4R. Mutagenesis studies revealed that Thr312 and Ser329/330 in the C-terminal tail are potential sites for PKA and GRK phosphorylation and may play an essential role in the recruitment of ß-arrestin to the activated receptor. Our data demonstrate that, through PKA-, GRK-, ß-arrestin-, and dynamin-dependent processes, MC4R undergoes internalization in response to agonist, thereby providing novel insights into the regulation of MC4R signaling.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
T. R. H. Buch, D. Heling, E. Damm, T. Gudermann, and A. Breit
Pertussis Toxin-sensitive Signaling of Melanocortin-4 Receptors in Hypothalamic GT1-7 Cells Defines Agouti-related Protein as a Biased Agonist
J. Biol. Chem., September 25, 2009; 284(39): 26411 - 26420.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J.-P. Fortin, Y. Zhu, C. Choi, M. Beinborn, M. N. Nitabach, and A. S. Kopin
Membrane-tethered ligands are effective probes for exploring class B1 G protein-coupled receptor function
PNAS, May 12, 2009; 106(19): 8049 - 8054.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Tan, I. D. Pogozheva, G. S. H. Yeo, D. Hadaschik, J. M. Keogh, C. Haskell-Leuvano, S. O'Rahilly, H. I. Mosberg, and I. S. Farooqi
Functional Characterization and Structural Modeling of Obesity Associated Mutations in the Melanocortin 4 Receptor
Endocrinology, January 1, 2009; 150(1): 114 - 125.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
B. M. Kublaoui, T. Gemelli, K. P. Tolson, Y. Wang, and A. R. Zinn
Oxytocin Deficiency Mediates Hyperphagic Obesity of Sim1 Haploinsufficient Mice
Mol. Endocrinol., July 1, 2008; 22(7): 1723 - 1734.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. A. Czyzyk, M. A. Sikorski, L. Yang, and G. S. McKnight
Disruption of the RII subunit of PKA reverses the obesity syndrome of agouti lethal yellow mice
PNAS, January 8, 2008; 105(1): 276 - 281.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. Hainerova, L. H. Larsen, B. Holst, M. Finkova, V. Hainer, J. Lebl, T. Hansen, and O. Pedersen
Melanocortin 4 Receptor Mutations in Obese Czech Children: Studies of Prevalence, Phenotype Development, Weight Reduction Response, and Functional Analysis
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3689 - 3696.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
G. Liu, J.-P. Fortin, M. Beinborn, and A. S. Kopin
Four Missense Mutations in the Ghrelin Receptor Result in Distinct Pharmacological Abnormalities
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1036 - 1043.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. Li, Y. Zhang, E. Rodrigues, D. Zheng, M. Matheny, K.-Y. Cheng, and P. J. Scarpace
Melanocortin activation of nucleus of the solitary tract avoids anorectic tachyphylaxis and induces prolonged weight loss
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E252 - E258.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Mohammad, G. Baldini, S. Granell, P. Narducci, A. M. Martelli, and G. Baldini
Constitutive Traffic of Melanocortin-4 Receptor in Neuro2A Cells and Immortalized Hypothalamic Neurons
J. Biol. Chem., February 16, 2007; 282(7): 4963 - 4974.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Breit, K. Wolff, H. Kalwa, H. Jarry, T. Buch, and T. Gudermann
The Natural Inverse Agonist Agouti-related Protein Induces Arrestin-mediated Endocytosis of Melanocortin-3 and -4 Receptors
J. Biol. Chem., December 8, 2006; 281(49): 37447 - 37456.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. A. Sebag and P. M. Hinkle
Regulation of Endogenous Melanocortin-4 Receptor Expression and Signaling by Glucocorticoids
Endocrinology, December 1, 2006; 147(12): 5948 - 5955.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Aja, S. Bi, S. B. Knipp, J. M. McFadden, G. V. Ronnett, F. P. Kuhajda, and T. H. Moran
Intracerebroventricular C75 decreases meal frequency and reduces AgRP gene expression in rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R148 - R154.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Z. Kilianova, N. Basora, P. Kilian, M. D. Payet, and N. Gallo-Payet
Human Melanocortin Receptor 2 Expression and Functionality: Effects of Protein Kinase A and Protein Kinase C on Desensitization and Internalization
Endocrinology, May 1, 2006; 147(5): 2325 - 2337.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. A. Nickolls, B. Fleck, S. R. J. Hoare, and R. A. Maki
Functional Selectivity of Melanocortin 4 Receptor Peptide and Nonpeptide Agonists: Evidence for Ligand-Specific Conformational States
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1281 - 1288.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. Sanchez-Mas, L. A. Guillo, P. Zanna, C. Jimenez-Cervantes, and J. C. Garcia-Borron
Role of G Protein-Coupled Receptor Kinases in the Homologous Desensitization of the Human and Mouse Melanocortin 1 Receptors
Mol. Endocrinol., April 1, 2005; 19(4): 1035 - 1048.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Guo, H. Munzberg, R. C. Stuart, E. A. Nillni, and C. Bjorbaek
N-acetylation of hypothalamic {alpha}-melanocyte-stimulating hormone and regulation by leptin
PNAS, August 10, 2004; 101(32): 11797 - 11802.
[Abstract] [Full Text] [PDF]

Home page
 J BiochemHome page
A. Blondet, M. Doghman, M. Rached, P. Durand, M. Begeot, and D. Naville
Characterization of Cell Lines Stably Expressing Human Normal or Mutated EGFP-Tagged MC4R
J. Biochem., April 1, 2004; 135(4): 541 - 546.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Valli-Jaakola, M. Lipsanen-Nyman, L. Oksanen, A. N. Hollenberg, K. Kontula, C. Bjorbaek, and C. Schalin-Jantti
Identification and Characterization of Melanocortin-4 Receptor Gene Mutations in Morbidly Obese Finnish Children and Adults
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 940 - 945.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Bluher, M. Ziotopoulou, J. W. Bullen Jr, S. J. Moschos, L. Ungsunan, E. Kokkotou, E. Maratos-Flier, and C. S. Mantzoros
Responsiveness to Peripherally Administered Melanocortins in Lean and Obese Mice
Diabetes, January 1, 2004; 53(1): 82 - 90.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Z. Gao, D. Lei, J. Welch, K. Le, J. Lin, S. Leng, and D. Duhl
Agonist-Dependent Internalization of the Human Melanocortin-4 Receptors in Human Embryonic Kidney 293 Cells
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 870 - 877.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society